Tagged: Global One Health
The Global One Health initiative (GOHi) collaborated with the Ethiopian Food and Drug Authority (EFDA) to undertake a causality assessment of adverse events following immunizations (AEFI) that were reported to the national pharmacovigilance unit at EFDA.
Members of the national pharmacovigilance advisory committee and pharmacovigilance experts and advisors from EFDA conducted the assessment. The team reviewed 11 cases of AEFIs following COVID-19 vaccines and the Novel Oral Polio Type 2 (NOPV2) vaccine for causality assessment and causal association determined.
The Ethiopian Public Health Institute (EPHI) recently recognized the Global One Health initiative (GOHi) for its outstanding contributions towards strengthening Ethiopia's national Public Health Emergency Management and laboratory system.
In a recent workshop, the EPHI reviewed the national COVID-19 response and discussed integrating COVID-19 response functions into the existing routine health system programs with national and regional stakeholders.
Sharon Santoso Clark is an internal medicine-pediatrics physician in the Division of Hospital Medicine at The Ohio State University Wexner Medical Center and the Section of Hospital Pediatrics at Nationwide Children's Hospital and a clinical assistant professor at The Ohio State University College of Medicine.
The Global One Health initiative (GOHi) hosted an Ethiopian Higher Education Leaders delegation from November 13-19, 2022. The delegation comprised 25 leaders from 16 public universities in Ethiopia and two from the Ministry of Education. The experiential visit is part of the Leadership, Management, and Governance (LMG) project implemented in Ethiopia by three U.S. universities: Texas Tech University, Oklahoma State University and The Ohio State University, in collaboration with the U.S. Embassy, Addis Ababa and the Ethiopian Federal Ministry of Education.
The Global One Health initiative (GOHi) provided on-site hand hygiene and environmental cleaning training to healthcare workers from Tikur Anbessa Specialized Hospital and Zewditu Memorial Hospital through an antimicrobial resistance project funded by the U.S. Centers for Disease Control and Prevention (CDC) in October 2022.
The Global One Health initiative (GOHi) Eastern Africa Office, in collaboration with U.S. Centers for Disease Control and Prevention (CDC), has been working to implement the Anti-Microbial Resistance (AMR) project. This project aims to strengthen antimicrobial resistance detection and response capacities in Zewditu Memorial Hospital and Tikur Anbessa Specialized Hospital.
The Global One Health initiative (GOHi) hosted training for 13 laboratory technology professionals from Ethiopian and Kenyan institutes at the Kenya Medical Research Institute (KEMRI) as part of the OHEART program.
The Ohio State Global One Health initiative (GOHi), through the U.S. Centers for Disease Control and Prevention (CDC) Coronavirus Aid, Relief, and Economic Security (CARES) Act, helped establish advanced molecular diagnostic laboratory capabilities. These labs will strengthen the national surveillance and response system by enabling the detection of infectious diseases such as influenza, COVID-19 and other pathogens of public health significance.
As part of the International Health Regulation (IHR)-U.S. Centers for Disease Control and Prevention (CDC) Coronavirus Aid, Relief and Economic Security (CARES) Act, the Global One Health initiative (GOHi) helped establish four molecular diagnostic laboratories for influenza and other respiratory pathogens testing in Addis Ababa, Bahir Dar, Arba Minch and Adama.
The Leadership, Management, and Governance (LMG) program in Ethiopian Higher Education aims to enhance the capacity of Ethiopian public higher education leaders. Funded by the U.S. Department of State's Bureau of African Affairs, the program is part of the Ministry of Education's strategy towards improving the overall governance of the higher education system in Ethiopia and enhancing the quality of education and research.